These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 17939895)

  • 1. Epidemiology and burden of herpes zoster and post-herpetic neuralgia in Australia, Asia and South America.
    Araújo LQ; Macintyre CR; Vujacich C
    Herpes; 2007 Sep; 14 Suppl 2():40-4. PubMed ID: 17939895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccination strategies for the prevention of herpes zoster and postherpetic neuralgia.
    Betts RF
    J Am Acad Dermatol; 2007 Dec; 57(6 Suppl):S143-7. PubMed ID: 18021866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel vaccine (Zostavax) to prevent herpes zoster and postherpetic neuralgia.
    Holcomb K; Weinberg JM
    J Drugs Dermatol; 2006 Oct; 5(9):863-6. PubMed ID: 17039651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Looking back to move forward: a twenty-year audit of herpes zoster in Asia-Pacific.
    Chen LK; Arai H; Chen LY; Chou MY; Djauzi S; Dong B; Kojima T; Kwon KT; Leong HN; Leung EM; Liang CK; Liu X; Mathai D; Pan JY; Peng LN; Poblete ER; Poi PJ; Reid S; Tantawichien T; Won CW
    BMC Infect Dis; 2017 Mar; 17(1):213. PubMed ID: 28298208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention strategies: herpes zoster, post-herpetic neuralgia and immunogenicity.
    Levin MJ; Schmader K
    Herpes; 2007 Sep; 14 Suppl 2():45-7. PubMed ID: 17939896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Active immunoprophylaxis to reduce clinical impact of Herpes Zoster and its complications].
    Marino MG; Bagnato B; Torella I; Franco E
    Ig Sanita Pubbl; 2009; 65(3):299-311. PubMed ID: 19629155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Varicella vaccination in Australia.
    Macartney KK; Beutels P; McIntyre P; Burgess MA
    J Paediatr Child Health; 2005 Nov; 41(11):544-52. PubMed ID: 16398834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of shingles by varicella zoster virus vaccination.
    Holodniy M
    Expert Rev Vaccines; 2006 Aug; 5(4):431-43. PubMed ID: 16989624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of herpes zoster and its painful and debilitating complications.
    Johnson R; McElhaney J; Pedalino B; Levin M
    Int J Infect Dis; 2007 Nov; 11 Suppl 2():S43-8. PubMed ID: 18162246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology, treatment and prevention of herpes zoster: A comprehensive review.
    Koshy E; Mengting L; Kumar H; Jianbo W
    Indian J Dermatol Venereol Leprol; 2018; 84(3):251-262. PubMed ID: 29516900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The burden of herpes zoster and postherpetic neuralgia in the United States.
    Weaver BA
    J Am Osteopath Assoc; 2007 Mar; 107(3 Suppl 1):S2-7. PubMed ID: 17488884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The epidemiology of varicella and herpes zoster in The Netherlands: implications for varicella zoster virus vaccination.
    de Melker H; Berbers G; Hahné S; Rümke H; van den Hof S; de Wit A; Boot H
    Vaccine; 2006 May; 24(18):3946-52. PubMed ID: 16564115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No evidence of family history as a risk factor for herpes zoster in patients with post-herpetic neuralgia.
    Gatti A; Pica F; Boccia MT; De Antoni F; Sabato AF; Volpi A
    J Med Virol; 2010 May; 82(6):1007-11. PubMed ID: 20419815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Herpes zoster and postherpetic neuralgia - prevention by vaccination?].
    Wutzler P
    Dtsch Med Wochenschr; 2009 Apr; 134 Suppl 2():S90-4. PubMed ID: 19353479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of the varicella vaccination program on herpes zoster epidemiology in the United States: a review.
    Reynolds MA; Chaves SS; Harpaz R; Lopez AS; Seward JF
    J Infect Dis; 2008 Mar; 197 Suppl 2():S224-7. PubMed ID: 18419401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology of Varicella-Zoster Virus in England and Wales.
    Brisson M; Edmunds WJ
    J Med Virol; 2003; 70 Suppl 1():S9-14. PubMed ID: 12627480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Modelling the impact of vaccination on the epidemiology of varicella zoster virus].
    Bonmarin I; Santa-Olalla P; Lévy-Bruhl D
    Rev Epidemiol Sante Publique; 2008 Oct; 56(5):323-31. PubMed ID: 18951741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Herpes zoster ophthalmicus natural history, risk factors, clinical presentation, and morbidity.
    Liesegang TJ
    Ophthalmology; 2008 Feb; 115(2 Suppl):S3-12. PubMed ID: 18243930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Herpes zoster and post-herpetic neuralgia in older adults].
    Lang PO; Zarate-Lagunes M; Pautex S
    Rev Med Suisse; 2008 Nov; 4(178):2398-402, 2404. PubMed ID: 19051627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the cost-effectiveness in the United States of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.
    Pellissier JM; Brisson M; Levin MJ
    Vaccine; 2007 Nov; 25(49):8326-37. PubMed ID: 17980938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.